miR-181a knockdown inhibits VEGF and MMP1 secretion in vitro.

Slides:



Advertisements
Similar presentations
VEGF gene expression in HPMVEC and VEGF protein levels in CM
Advertisements

SCLCs and LCNECs are sensitive to PARP inhibition in vitro.
IL-1β differentially regulates CXCL5 and CXCL8 protein secretion in NHTBE and NSCLC cells. IL-1β differentially regulates CXCL5 and CXCL8 protein secretion.
IL-1β stimulates CXCL5 and CXCL8 gene expression and protein secretion in A549 cells in a time- and dose-dependent manner. IL-1β stimulates CXCL5 and CXCL8.
miR-133a positively regulated p53/p21 pathway.
Pirh2 promotes p73 ubiquitination in vivo.
Proline supplementation during P5CS protein knockdown suppressed GCN2 activation. Proline supplementation during P5CS protein knockdown suppressed GCN2.
Dihydromyricetin decreases the sphere formation through downregulation of Sox2 in human osteosarcoma. Dihydromyricetin decreases the sphere formation through.
miR-335 targeted RANKL and reduced osteoclast induction in SBC-5.
Interfering with HMGA2 expression blocks transformation in metastatic lung cancer cells. Interfering with HMGA2 expression blocks transformation in metastatic.
Inhibition of β-catenin by the Smad4/BMP pathway.
Mechanism of Smad1/5 activation by rapamycin.
eIF5A-PEAK1 signaling regulates KRAS protein expression.
Knocking down Wnt3 increases the cells' response to trastuzumab and reduces cells' invasiveness. Knocking down Wnt3 increases the cells' response to trastuzumab.
Knockdown of endogenous WT-hTER by a short hairpin RNA (siRNA) directed specifically against the human WT telomerase RNA template. Knockdown of endogenous.
A, B, apoptosis analysis using Annexin V-FITC/PI was done on 5th, 7th, and 9th day after transfection either with si control or si AEBP1in U87MG and U138MG.
Quantification of NMT knockdown.
Targeting eIF4E increases ZEB1 protein and mRNA levels and decreases ZEB1-targeting miR-200c and miR-141 microRNAs. Targeting eIF4E increases ZEB1 protein.
TFAP2A interacts with HIF-1α and regulates VEGF expression and cell proliferation. TFAP2A interacts with HIF-1α and regulates VEGF expression and cell.
Cell viability assay and expression of COX protein.
TFAP2A is highly expressed in nasopharyngeal carcinoma cells and tumor tissues. TFAP2A is highly expressed in nasopharyngeal carcinoma cells and tumor.
A, IGFBP-3 knockdown via siRNA using real-time qRT-PCR analysis.
PX-478 inhibits hypoxic HIF-1 protein expression and signaling activity in a dose-dependent manner. PX-478 inhibits hypoxic HIF-1 protein expression and.
Effect of LY on phosphorylation of various MAP kinase substrates in HeLa cells in vitro. Effect of LY on phosphorylation of various MAP kinase.
Activation of CHOP and DR5 by DIM-C-pPhtBu.
Imatinib mesylate inhibits PDGF-mediated ERK and Akt activation.
Overexpression of miR-335, but not miR-29a, reduces in vitro carcinogenesis. Overexpression of miR-335, but not miR-29a, reduces in vitro carcinogenesis.
TGF-β1 modulates extracellular matrix–mediated MT1-MMP expression.
Mcl-1 knockdown promotes cleavage of caspase-3 in nonadherent melanoma cells. Mcl-1 knockdown promotes cleavage of caspase-3 in nonadherent melanoma cells.
Sensor siRNAs can be used in high-order combinations.
VEGF expression in neoplastic and normal prostate tissue.
MiR-200c is a PI3K–AKT signaling pathway regulator in CRC
Expression of CRC stem cell markers and L1 in CRC cells.
Knockdown of PKM2 suppressed TPA-induced skin cell transformation.
Effect of SFN on the protein expression of Nrf2, HO-1, and NQO1 in JB6-shMock and JB6-shNrf2 cells. Effect of SFN on the protein expression of Nrf2, HO-1,
TFAP2A knockdown inhibits cell growth by targeting HIF-1α signaling.
In vivo tumorigenicity of MKN-1 cells with sustained suppression of HDAC2. In vivo tumorigenicity of MKN-1 cells with sustained suppression of HDAC2. A,
Src expression in a panel of human TCC cell lines.
Targeting DCLK1 by miRNA-137.
Effect of GSK3β inhibition on cell survival and proliferation of glioblastoma cells. Effect of GSK3β inhibition on cell survival and proliferation of glioblastoma.
A, Western blot analysis of vascular endothelial growth factor-C (VEGF-C). A, Western blot analysis of vascular endothelial growth factor-C (VEGF-C). Concentrated.
SBC-5 miR-335+, but not SBC-5 miR-29a+, exhibited reduced IGF-IR expression. SBC-5 miR-335+, but not SBC-5 miR-29a+, exhibited reduced IGF-IR expression.
Effects of HDAC2 inactivation on the invasive potential of human gastric cancer cells. Effects of HDAC2 inactivation on the invasive potential of human.
miR-100 suppresses bladder cancer cell growth in vitro and in vivo.
Isolation of stable XPAKD and XPCKD HeLa clones.
Characterization of DNA-PK and PARP-1 levels and activities in the cell lines studied. Characterization of DNA-PK and PARP-1 levels and activities in the.
Met is expressed in Her2-overexpressing cell lines and Her2 (+) breast tumors. Met is expressed in Her2-overexpressing cell lines and Her2 (+) breast tumors.
Substitution of endogenous Reptin with D299N mutant leads to HuH7 cell growth arrest. Substitution of endogenous Reptin with D299N mutant leads to HuH7.
FBXL19-AS1 knockdown inhibits proliferation, migration and invasion, and reduces the expression levels of angiogenesis related proteins in lung cancer.
Enhanced expression of Cap43 gene by nickel in breast cancer cell lines. Enhanced expression of Cap43 gene by nickel in breast cancer cell lines. Expression.
VEGF165 stimulates migration of HMVECs
Comparison of Akt1 and Akt3 for their abilities to activate the Fra-1 promoter. Comparison of Akt1 and Akt3 for their abilities to activate the Fra-1 promoter.
AS1411 alters subcellular distribution of PRMT5 in a time-dependent, dose-dependent, and nucleolin-dependent manner. AS1411 alters subcellular distribution.
SAHA blocks IR-induced increase of RAD51 protein in MM cells.
Effects of ASGR2 knockdown on the phenotypes of MKN1 cells.
Effect of bevacizumab on the proliferation of A2780 cells.
HOXA11-AS acts as a ceRNA for miR-1297.
BEZ235 induces accelerated senescence after radiation (IR) in vitro.
Establishment of HeLa/rtTAA/TRE-N1-IC cell line.
Depleting NQO1 expression levels inhibits growth of NSCLC cells in soft agar. Depleting NQO1 expression levels inhibits growth of NSCLC cells in soft agar.
Elevated STAT3 phosphorylation and RANTES levels in tamoxifen-treated breast cancer cells. Elevated STAT3 phosphorylation and RANTES levels in tamoxifen-treated.
Human melanoma induces paracrine β-catenin signaling activation in DCs in vitro. Human melanoma induces paracrine β-catenin signaling activation in DCs.
Effect of SFN on the total activity and protein expression of HDACs in JB6 P+ cells. Effect of SFN on the total activity and protein expression of HDACs.
Effects of NMT siRNAs on MARCKS and c-Src.
Inhibition of HDACs disrupts DNMT1 association with Hsp90.
RGS16 expression is decreased in chondrosarcoma and RGS16 transfection counteracts the effects of miR-181a on VEGF and MMP1 expression. RGS16 expression.
Knockdown of NR4A1 induces endoplasmic reticulum stress–mediated apoptosis by increasing ROS production in pancreatic cancer cells. Knockdown of NR4A1.
Loss of NQO1 expression inhibits invasion of NSCLC
Silencing E4BP4 abrogates the promoting effect of SMAD3 knockdown on IFNγ production in NK-92 cells. Silencing E4BP4 abrogates the promoting effect of.
Time course of NMT knockdown.
Presentation transcript:

miR-181a knockdown inhibits VEGF and MMP1 secretion in vitro. miR-181a knockdown inhibits VEGF and MMP1 secretion in vitro. VEGF and pro-MMP1 in CM were analyzed with ELISA and Western blotting, as described in Materials and Methods. A and B, CS-1 cells were transfected with anti–miR-181a at various concentrations and VEGF and MMP1 in CM measured after 2 days. C and D, CS-1 cells were transfected with 40 nmol/L anti–miR-181a and VEGF and MMP1 were measured for 3 days with ELISA and on day 2 with Western blotting (E). CS-1 cells (F and G) and JJ cells (H and I) were transfected with miR-181a or control or lentivirus expression construct with anti–miR-181a or control and VEGF and MMP1 concentration measured 2 days after transfection; *, P < 0.001; #, P < 0.01. Xiaojuan Sun et al. Mol Cancer Res 2015;13:1347-1357 ©2015 by American Association for Cancer Research